Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

Quest Diagnostics to develop blood test to aid in the detection of colorectal cancer

Feb. 21, 2008

mtm Laboratories launches Cervatec assay for cervical cancer

Feb. 7, 2008

Decreased VLDLR expression may be a biomarker for schizophrenia

Jan. 22, 2008

New role for endogenous microRNAs in cancer metastasis discovered

Jan. 16, 2008

Amic enters license agreement with Roche Diagnostics for test for cardiac marker NT-proBNP

Jan. 4, 2008

HealthLinx successfully completes phase II biomarker trial on the OvPlex panel

Nov. 20, 2007

Panacea makes CC Detect available as diagnostic test for colon cancer

Nov. 20, 2007

bioMerieux receives FDA clearance for sepsis biomarker assay

Oct. 24, 2007

AMDL seeks FDA approval for ELISA tumor marker test

Oct. 18, 2007

Polyunsaturated fatty acid erythrocyte content, biomarker of colorectal cancer risk

Oct. 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...